Skip to main content
oAv Menu
Home
Patient Care Center
Clinical Trials
Providers
Therapeutics
People
Places
Community Center
Community Stories
Social Media
Community Content
Financial Assistance
News
Community Events
Clinical Trials and Research
Business
News People
Happenings
Spotlight
Fundraising Events
Trusted Resources
Education
Videos & Visuals
Event Calendar
Login
Search
Tegsedi (inotersen)
Home
Tegsedi (inotersen)
Jul 04, 2018
Inotersen Treatment for Patients With Hereditary Transthyretin Amyloidosis
Read more
Tegsedi™ to be Available on the NHS for hATTR Amyloidosis
Read more
ESC: Tafamidis Cuts Deaths, Admissions in TTR Cardiac Amyloidosis
Read more
FDA OKs Inotersen (Tegsedi) for Hereditary ATTR With Polyneuropathy
Read more
Inotersen: An Exciting Prospect for hATTR Amyloidosis Treatment
Read more
Subscribe to